tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

AU:RCE

Recce Pharmaceuticals Updates Trading Policy
Company AnnouncementsRecce Pharmaceuticals Updates Trading Policy
20d ago
Recce Pharmaceuticals Expands Market Presence
PremiumCompany Announcements
Recce Pharmaceuticals Expands Market Presence
20d ago
Recce Pharmaceuticals Bolsters Clinical Trial Funds
PremiumCompany Announcements
Recce Pharmaceuticals Bolsters Clinical Trial Funds
21d ago
Recce Pharmaceuticals Achieves Key Milestones
PremiumCompany Announcements
Recce Pharmaceuticals Achieves Key Milestones
1M ago
Recce Pharmaceuticals Secures $2M Defense Grant
PremiumCompany Announcements
Recce Pharmaceuticals Secures $2M Defense Grant
1M ago
Recce Pharmaceuticals Appoints New Auditor
PremiumCompany AnnouncementsRecce Pharmaceuticals Appoints New Auditor
2M ago
Recce Pharmaceuticals Announces Positive Preclinical Efficacy Data Against WHO Priority Pathogen Acinetobacter baumannii
Premium
Press Releases
Recce Pharmaceuticals Announces Positive Preclinical Efficacy Data Against WHO Priority Pathogen Acinetobacter baumannii
2M ago
Recce Pharmaceuticals Launches Share Purchase Plan
Premium
Company Announcements
Recce Pharmaceuticals Launches Share Purchase Plan
2M ago
Recce Pharmaceuticals Seeks ASX Quotation Expansion
PremiumCompany Announcements
Recce Pharmaceuticals Seeks ASX Quotation Expansion
2M ago
Recce Pharma’s Drug Shows Superbug Combat Success
PremiumCompany Announcements
Recce Pharma’s Drug Shows Superbug Combat Success
2M ago
Recce Pharmaceuticals Launches Share Placement
PremiumCompany Announcements
Recce Pharmaceuticals Launches Share Placement
2M ago
Recce Pharmaceuticals Secures $8M for Clinical Trials
PremiumCompany Announcements
Recce Pharmaceuticals Secures $8M for Clinical Trials
2M ago
Recce Pharmaceuticals Reports Positive Data from Phase I/II Urinary Tract Infection (UTI) / Urosepsis Rapid Infusion Trial of RECCE® 327
PremiumPress ReleasesRecce Pharmaceuticals Reports Positive Data from Phase I/II Urinary Tract Infection (UTI) / Urosepsis Rapid Infusion Trial of RECCE® 327
2M ago
Recce Pharmaceuticals Halts Trading Ahead of Capital Raise
Premium
Company Announcements
Recce Pharmaceuticals Halts Trading Ahead of Capital Raise
2M ago
Recce Pharmaceuticals’ Promising UTI Drug Trial
Premium
Company Announcements
Recce Pharmaceuticals’ Promising UTI Drug Trial
2M ago
Recce Pharmaceuticals Receives Ethics Approval to Broaden RECCE® 327 Gel Trials Across all Topical Bacterial Skin Infections
PremiumPress Releases
Recce Pharmaceuticals Receives Ethics Approval to Broaden RECCE® 327 Gel Trials Across all Topical Bacterial Skin Infections
2M ago
Recce Pharmaceuticals Advances ABSSSI Gel Trials
PremiumCompany Announcements
Recce Pharmaceuticals Advances ABSSSI Gel Trials
2M ago
Recce Pharmaceuticals Announces Addition of RECCE® 327 to The World Health Organization’s List of Antibacterial Products in Clinical Development
PremiumPress Releases
Recce Pharmaceuticals Announces Addition of RECCE® 327 to The World Health Organization’s List of Antibacterial Products in Clinical Development
2M ago
Recce Pharmaceuticals Secures R&D Tax Rebate
PremiumCompany Announcements
Recce Pharmaceuticals Secures R&D Tax Rebate
2M ago
Recce’s R327 Gains WHO Recognition in Antibiotic Resistance Fight
PremiumCompany AnnouncementsRecce’s R327 Gains WHO Recognition in Antibiotic Resistance Fight
2M ago
Recce Pharmaceuticals Advances in UTI/Urosepsis Trial
Premium
Company Announcements
Recce Pharmaceuticals Advances in UTI/Urosepsis Trial
3M ago
Recce Pharmaceuticals Spotlighted at Military Health Symposium
Premium
Company Announcements
Recce Pharmaceuticals Spotlighted at Military Health Symposium
3M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >